Cabot Corporation (CBT) is listed on NYSE in Chemical Stocks. It is $83.64, -1.11%, with a $4.3B market cap. RSI is 40.7, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 40.7 Neutral
Market Cap $4.3B
Volume 178.1K
Fundamentals — 10-Q Q3 2026
Revenue $2.7B
Net Income $147.0M
EPS $2.77
Gross Margin 22.1%
Operating Margin 13.0%
Net Margin 5.4%
Debt / Equity 0.5x
P/E Ratio 30.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Keohane Sean D | President and CEO | Sell | 2,779 | $85.50 | $237,605 | 2026 Aug 24 |
| Keohane Sean D | President and CEO | Sell | 91,923 | $86.41 | $7.9M | 2026 Aug 7 |
| Keohane Sean D | President and CEO | Sell | 114,436 | $79.28 | $9.1M | 2025 Aug 14 |
| Zhu Jeff Ji | Executive Vice President | Sell | 14,566 | $113.25 | $1.6M | 2024 Nov 13 |
| Dumont Lisa M | VP, Controller & CAO | Sell | 865 | $111.74 | $96,655 | 2024 Nov 13 |
| Kalkstein Hobart | Executive Vice President | Sell | 34,759 | $115.23 | $4.0M | 2024 Nov 11 |
| Keohane Sean D | President and CEO | Sell | 25,617 | $101.55 | $2.6M | 2024 Sep 3 |
| Zhu Jeff Ji | Executive Vice President | Sell | 14,912 | $104.05 | $1.6M | 2024 Aug 27 |
| McLaughlin Erica | Executive Vice President, CFO | Sell | 16,390 | $104.24 | $1.7M | 2024 Aug 27 |
| Kalkstein Hobart | Executive Vice President | Sell | 20,320 | $100.82 | $2.0M | 2024 Aug 20 |
| McLaughlin Erica | Executive Vice President, CFO | Sell | 11,082 | $98.08 | $1.1M | 2024 Aug 8 |
| McLaughlin Erica | Executive Vice President, CFO | Sell | 23,274 | $99.79 | $2.3M | 2024 Aug 7 |
| Kalkstein Hobart | Executive Vice President | Sell | 12,187 | $101.57 | $1.2M | 2024 May 16 |
| Kalita Karen A | SVP and General Counsel | Sell | 13,764 | $101.73 | $1.4M | 2024 May 10 |
| Kalkstein Hobart | Executive Vice President | Sell | 7,648 | $88.01 | $673,100 | 2024 Mar 7 |
| Keohane Sean D | President and CEO | Sell | 17,857 | $85.43 | $1.5M | 2024 Mar 1 |
| Zhu Jeff Ji | Executive Vice President | Sell | 55,233 | $79.91 | $4.4M | 2024 Feb 13 |
| McLaughlin Erica | Executive Vice President, CFO | Sell | 36,119 | $81.79 | $3.0M | 2023 Dec 14 |
| Kalita Karen A | SVP and General Counsel | Sell | 22,574 | $77.78 | $1.8M | 2023 Nov 21 |
| Kalkstein Hobart | Executive Vice President | Sell | 50,692 | $73.91 | $3.7M | 2023 Nov 10 |
Other Chemical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $489.49 | 46.5 | $225.6B |
| | $308.11 | 57.7 | $68.6B |
| | $30.51 | 48.0 | $22.0B |
| | $9.47 | 33.8 | $1.7B |
| | $166.14 | 58.9 | $2.9B |
Take CBT further
- Browse Chemical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put CBT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Cabot Corporation next reports.
Set alerts on CBT
Get notified when Cabot Corporation hits your price targets or technical conditions are met.
Get Started Free